DK2470545T3 - Anhydrate former af et pyridinderivat - Google Patents
Anhydrate former af et pyridinderivatInfo
- Publication number
- DK2470545T3 DK2470545T3 DK10747619.4T DK10747619T DK2470545T3 DK 2470545 T3 DK2470545 T3 DK 2470545T3 DK 10747619 T DK10747619 T DK 10747619T DK 2470545 T3 DK2470545 T3 DK 2470545T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridine derivative
- anhydrate forms
- anhydrate
- forms
- pyridine
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23743509P | 2009-08-27 | 2009-08-27 | |
| PCT/EP2010/062420 WO2011023733A1 (en) | 2009-08-27 | 2010-08-25 | Anhydrate forms of a pyridine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2470545T3 true DK2470545T3 (da) | 2014-01-13 |
Family
ID=42790943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10747619.4T DK2470545T3 (da) | 2009-08-27 | 2010-08-25 | Anhydrate former af et pyridinderivat |
Country Status (18)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2470545T3 (pl) * | 2009-08-27 | 2014-03-31 | Nerre Therapeutics Ltd | Bezwodne postaci pochodnej pirydyny |
| WO2015200594A2 (en) * | 2014-06-25 | 2015-12-30 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
| CN114306347A (zh) * | 2015-05-18 | 2022-04-12 | 康堤医疗有限公司 | 用于治疗性激素依赖性疾病的双重nk-1/nk-3受体拮抗剂 |
| CA3044773A1 (en) * | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activators |
| DK3765024T3 (da) | 2018-03-14 | 2024-02-12 | Kandy Therapeutics Ltd | Hidtil ukendt farmaceutisk formulering, som omfatter dobbelte nk-1/nk-3-receptor-antagonister |
| WO2021030335A1 (en) * | 2019-08-12 | 2021-02-18 | Millendo Therapeutics, Inc. | A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof |
| JP7673064B2 (ja) * | 2019-11-15 | 2025-05-08 | カンディー セラピューティクス リミテッド | Ｎｔ－８１４の重要な中間体である６－クロロ－４－（４－フルオロ－２－メチルフェニル）ピリジン－３－アミンを作製するための新規な化学的方法 |
| EP4431512A1 (en) | 2023-03-16 | 2024-09-18 | Bayer Consumer Care AG | Novel dual nk-1/nk-3 receptor antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE496032T1 (de) * | 1999-02-24 | 2011-02-15 | Hoffmann La Roche | 4-phenylpyridinderivate und deren verwendung als nk-1 rezeptorantagonisten |
| GB0203022D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| ATE366576T1 (de) * | 2003-01-31 | 2007-08-15 | Hoffmann La Roche | Neue kristallmodifikation von 2-(3,5-bis- trifluormethyl-phenyl)-n-6-(1,1-dioxo-1lamda-6- |
| AU2004253267B2 (en) * | 2003-07-03 | 2008-12-04 | F. Hoffmann-La Roche Ag | Dual NK1/NK3 antagonists for treating schizophrenia |
| PT1928886E (pt) * | 2005-09-09 | 2011-07-14 | Glaxosmithkline Llc | Derivados de piridina e sua utilização para o tratamento de distúrbios psicóticos |
| US20100190797A1 (en) * | 2007-12-11 | 2010-07-29 | Cipla Ltd. | Crystalline polymophic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
| GB0814340D0 (en) * | 2008-08-05 | 2008-09-10 | Smithkline Beecham Corp | Anhydrous crystol form fo a pyridine derivative |
| PL2470545T3 (pl) * | 2009-08-27 | 2014-03-31 | Nerre Therapeutics Ltd | Bezwodne postaci pochodnej pirydyny |
| JP6342662B2 (ja) * | 2014-01-29 | 2018-06-13 | 京セラ株式会社 | ドリルおよびそれを用いた切削加工物の製造方法 |
-
2010
- 2010-08-25 PL PL10747619T patent/PL2470545T3/pl unknown
- 2010-08-25 EA EA201270302A patent/EA021411B1/ru not_active IP Right Cessation
- 2010-08-25 US US13/389,525 patent/US8796269B2/en active Active
- 2010-08-25 MX MX2012002369A patent/MX2012002369A/es active IP Right Grant
- 2010-08-25 AU AU2010288502A patent/AU2010288502B2/en active Active
- 2010-08-25 IN IN1292DEN2012 patent/IN2012DN01292A/en unknown
- 2010-08-25 KR KR1020127004865A patent/KR20120056258A/ko not_active Ceased
- 2010-08-25 ES ES10747619.4T patent/ES2440938T3/es active Active
- 2010-08-25 BR BR112012003435A patent/BR112012003435A2/pt not_active Application Discontinuation
- 2010-08-25 EP EP10747619.4A patent/EP2470545B1/en active Active
- 2010-08-25 WO PCT/EP2010/062420 patent/WO2011023733A1/en active Application Filing
- 2010-08-25 CA CA2772168A patent/CA2772168C/en active Active
- 2010-08-25 DK DK10747619.4T patent/DK2470545T3/da active
- 2010-08-25 SG SG2012007464A patent/SG178231A1/en unknown
- 2010-08-25 JP JP2012526048A patent/JP2013503134A/ja active Pending
- 2010-08-25 CN CN201080037918.3A patent/CN102639536B/zh active Active
-
2012
- 2012-02-02 IL IL217922A patent/IL217922A/en active IP Right Grant
- 2012-02-02 ZA ZA2012/00812A patent/ZA201200812B/en unknown
-
2015
- 2015-07-13 JP JP2015139845A patent/JP6404186B2/ja active Active
-
2017
- 2017-06-09 JP JP2017114602A patent/JP2017193564A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL217922A0 (en) | 2012-03-29 |
| IN2012DN01292A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-06-05 |
| EP2470545B1 (en) | 2013-10-09 |
| JP2013503134A (ja) | 2013-01-31 |
| KR20120056258A (ko) | 2012-06-01 |
| IL217922A (en) | 2016-06-30 |
| US8796269B2 (en) | 2014-08-05 |
| AU2010288502B2 (en) | 2013-12-12 |
| ES2440938T3 (es) | 2014-01-31 |
| JP6404186B2 (ja) | 2018-10-10 |
| CN102639536B (zh) | 2015-03-18 |
| CN102639536A (zh) | 2012-08-15 |
| EA021411B1 (ru) | 2015-06-30 |
| CA2772168C (en) | 2019-01-08 |
| CA2772168A1 (en) | 2011-03-03 |
| AU2010288502A1 (en) | 2012-02-23 |
| SG178231A1 (en) | 2012-03-29 |
| BR112012003435A2 (pt) | 2016-02-23 |
| PL2470545T3 (pl) | 2014-03-31 |
| MX2012002369A (es) | 2012-03-29 |
| EP2470545A1 (en) | 2012-07-04 |
| JP2016000739A (ja) | 2016-01-07 |
| JP2017193564A (ja) | 2017-10-26 |
| ZA201200812B (en) | 2013-03-27 |
| WO2011023733A1 (en) | 2011-03-03 |
| US20120157450A1 (en) | 2012-06-21 |
| EA201270302A1 (ru) | 2012-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2021505I1 (lt) | Pakeistojo policiklinio karbamoilpiridono darinio provaistas | |
| HUS2000005I1 (hu) | Diamino-heterociklusos karboxamid-vegyület | |
| EP2404918A4 (en) | pyridine | |
| EP2519522A4 (en) | SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS | |
| DK2262793T3 (da) | Krystallinske former af nilotinib-hci | |
| DK2470545T3 (da) | Anhydrate former af et pyridinderivat | |
| HRP20180646T1 (hr) | Dispiropirolidinski derivat | |
| DK2268160T3 (da) | Emulsioner omfattende et PEG-derivat af tokoferol | |
| ECSP12011999A (es) | Derivados benzamida sustituidos | |
| DK3703369T3 (da) | Fusion af prøveområder | |
| FI20095666A0 (fi) | Hitsauksen optimointi | |
| DK2404485T3 (da) | Automatisk konfigurering af en belysning | |
| BRPI1011683A2 (pt) | derivado isoquinolina substituída | |
| DK2260153T3 (da) | Brandbeskyttelse af et strukturelt element | |
| EP2404030A4 (en) | RECOVERING WELL REINFORCING MATERIAL | |
| EP2508513A4 (en) | 2-PYRIDONES COMPOUNDS | |
| BR112012005960A2 (pt) | n-fenil-1-(4-piridinil)-1h-pirazol-3-aminas substituídas | |
| DK2358714T3 (da) | Alkylcyclohexylethere af dihydrotetraazabenzoazulener | |
| SMT201500268B (it) | Derivato di 5-idrossipirimidin-4-carbossammide | |
| BR112012002807A2 (pt) | derivados de 5-flúor-2-oxopirimidina-1(2h)-caboxilato | |
| EP2519519A4 (en) | Substituted Naphthalenyl-pyrimidine compounds | |
| PL2488157T3 (pl) | Ulepszone preparaty | |
| DK2217006T3 (da) | Et høreapparat | |
| DK2302952T3 (da) | Selvtilpasning af et hørehjælpeapparat | |
| CO6970612A2 (es) | Derivados de alcanol heterocíclicos novedosos |